Evogene (EVGN) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free EVGN Stock Alerts $0.67 +0.01 (+1.52%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEvogene (NASDAQ:EVGN) Share Price Crosses Below Two Hundred Day Moving Average of $0.74americanbankingnews.com - April 24 at 4:32 AMEvogene (NASDAQ:EVGN) Coverage Initiated at StockNews.comamericanbankingnews.com - April 24 at 2:38 AMBiomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meetingprnewswire.com - April 11 at 7:00 AMEvogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industryfinance.yahoo.com - April 2 at 10:15 AMEvogene Announces Filing of Annual Report on Form 20-Fprnewswire.com - March 28 at 9:00 AMEvogene Reports Receipt of Nasdaq Minimum Bid Price Notificationprnewswire.com - March 20 at 9:00 AMBayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testingprnewswire.com - March 19 at 9:00 AMEvogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 8 at 4:52 PMEVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 7 at 2:01 PMEvogene: EPS übertrifft Schätzungen um 0,01 $ - Umsatz schlechter als erwartetde.investing.com - March 7 at 7:35 AMEvogene Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - March 7 at 7:35 AMAgPlenus Ltd.: AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicidesfinanznachrichten.de - March 6 at 5:40 PMHere's what Wall Street expects from Evogene's earnings reportmarkets.businessinsider.com - March 6 at 5:40 PMEvogene Earnings Previewbenzinga.com - March 6 at 5:40 PMAgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicidesfinance.yahoo.com - March 6 at 5:40 PMCasterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varietiesprnewswire.com - March 5 at 7:00 AMLavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirementsprnewswire.com - February 28 at 7:00 AMEvogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024finance.yahoo.com - February 26 at 10:06 AMEvogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024prnewswire.com - February 26 at 7:00 AMAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officerprnewswire.com - February 22 at 7:00 AMBayer schwankt, deutliche Gewinnmitnahmen bei Renk, Zweifel um Nvidia und auch bei Super Micro Computer ist die Luft rausfinanznachrichten.de - February 21 at 10:22 PMAgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solutionfinance.yahoo.com - February 21 at 7:19 AMAgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solutionprnewswire.com - February 21 at 7:00 AMSyngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticideprnewswire.com - February 20 at 7:00 AMSyngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticidebusinesswire.com - February 20 at 7:00 AMBiomica Ltd.: Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drugfinanznachrichten.de - January 17 at 9:52 AMLavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™finance.yahoo.com - December 5 at 8:00 AMLavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barleyfinance.yahoo.com - November 28 at 8:29 AMIsraeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challengesbenzinga.com - November 16 at 10:21 AMEvogene Ltd. (NASDAQ:EVGN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 16 at 10:21 AMRecap: Evogene Q3 Earningsbenzinga.com - November 15 at 8:07 AMEvogene Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 15 at 8:07 AMEvogene earnings: here's what Wall Street expectsmarkets.businessinsider.com - November 14 at 12:06 PMA Preview Of Evogene's Earningsbenzinga.com - November 14 at 12:06 PMLavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Resultsfinance.yahoo.com - November 8 at 7:42 AMEvogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023finance.yahoo.com - November 2 at 8:23 AMColors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technologyfinance.yahoo.com - October 31 at 8:29 AMEvogene (EVGN) Price Target Increased by 12.50% to 4.59msn.com - August 31 at 6:19 PMEvogene (EVGN) Could Find a Support Soon, Here's Why You Should Buy the Stock Nowfinance.yahoo.com - August 21 at 6:13 PMEvogene Ltd. (NASDAQ:EVGN) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 21 at 6:13 PMLake Street Maintains Buy Rating for Evogene: Here's What You Need To Knowmarkets.businessinsider.com - August 18 at 4:28 PMEvogene (EVGN) Receives a Buy from Lake Streetmarkets.businessinsider.com - August 17 at 3:17 PMEvogene Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 17 at 10:12 AMEvogene (EVGN) Reports Q2 Loss, Lags Revenue Estimatesfinance.yahoo.com - August 17 at 10:12 AMEvogene earnings preview: what Wall Street is expectingmarkets.businessinsider.com - August 16 at 5:39 PMEvogene Q2 2023 Earnings Previewmsn.com - August 16 at 5:39 PMBiomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Centerfinance.yahoo.com - August 15 at 8:45 AMEvogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023finance.yahoo.com - August 1 at 3:46 PMEvogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discoveryfinance.yahoo.com - July 25 at 8:54 AMRoth MKM Maintains Evogene (EVGN) Buy Recommendationmsn.com - July 22 at 12:36 PM Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… EVGN Media Mentions By Week EVGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVGN News Sentiment▼0.340.44▲Average Medical News Sentiment EVGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVGN Articles This Week▼21▲EVGN Articles Average Week Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACST News Today ICU News Today FBRX News Today SLGL News Today MOVE News Today QLI News Today DRRX News Today TVGN News Today ITRM News Today WINT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVGN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
